Joseph Glorioso, PhD
Composed of leading researchers and innovators in the field of cancer research, ACGT’s Scientific Advisory Council sets research priorities for ACGT, provides peer review of grant proposals and oversees ACGT-funded studies. Under the new chairmanship of Joseph Glorioso, PhD, four new members have joined the team. In addition to being outstanding researchers in their own right, these four scientists bring their tremendous experience from the academic/biotech/pharmaceutical arenas and, together with our current Scientific Advisory Council members, will advise ACGT on future academic and industry partnerships.
The scientific advisors we welcome to the council are:
- John Bell, PhD, Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute, and a 2013/14 ACGT Research Fellow for brain cancer research.
- E. Antonio Chiocca, MD, PhD, FAANS, Neurosurgeon-in-Chief and Chairman, Department of Neurosurgery Brigham and Women’s Hospital, and 2007 ACGT Research Fellow for brain cancer research
- Mitchell H. Finer, PhD, Founder and Senior Consultant, Avalanche Biotechnologies; former Chief Scientific Officer, Bluebird Bio
- Dario A. Vignali, PhD, Vice-Chair, Department of Immunology and Co-Leader, Cancer Immunology Program, University of Pittsburgh.